Stay updated on Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Sign up to get notified when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.

Latest updates to the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a minor platform/version change for the ClinicalTrials.gov interface.SummaryDifference0.0%

- Check8 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now lists Revision: v3.4.3 and removes Revision: v3.4.2.SummaryDifference0.0%

- Check65 days agoChange DetectedDrug/substrate details and other study logistics were removed. Specifically, multiple medications and trial-related sections such as the DDI components, study plan, eligibility criteria, and locations are no longer shown.SummaryDifference18%

- Check73 days agoChange DetectedA minor revision note was updated from v3.4.1 to v3.4.2; no clinical content or page structure changes are apparent. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Ecztra 4: Tralokinumab Drug Interaction Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ecztra 4: Tralokinumab Drug Interaction Clinical Trial page.